Sumitomo Dainippon Pharma Co Ltd (4506)-Financial and Strategic SWOT Analysis Review

Sumitomo Dainippon Pharma Co Ltd (4506)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH6665FSA
  • |
  • Pages: 54
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Sumitomo Dainippon Pharma Co Ltd (4506)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co., Ltd, develops manufacturers, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, diabetes, oncology, respiratory psychiatry and neurology and infectious diseases. It also offers veterinary products, research materials, food additives, chemical product materials, food ingredients, diagnostic agents, cosmetic materials and other products. Sumitomo Dainippon has research laboratories, manufacturing and distribution facilities in Japan. The company operates through subsidiaries and offices in the North America, Europe and Asia Pacific. Sumitomo Dainippon is headquartered in Chuo-ku, Osaka, Japan.

Sumitomo Dainippon Pharma Co Ltd Key Recent Developments

Jul 04,2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S.

Jun 16,2017: Sumitomo Dainippon Pharma announces personnel change

Jun 01,2017: Sumitomo Dainippon Pharma Contributes funding to the Global Health Innovative Technology Fund (GHIT Fund) for the Second Period

May 08,2017: Sumitomo Dainippon Pharma announces personnel change

Apr 10,2017: Hitachi is selected by Sumitomo Dainippon Pharma for Automated Cell Mass Culture Equipment for Regenerative Medicine using Human iPS Cells

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Sumitomo Dainippon Pharma Co Ltd-Key Facts 6

Sumitomo Dainippon Pharma Co Ltd-Key Employees 7

Sumitomo Dainippon Pharma Co Ltd-Key Employee Biographies 9

Sumitomo Dainippon Pharma Co Ltd-Major Products and Services 10

Sumitomo Dainippon Pharma Co Ltd-History 11

Sumitomo Dainippon Pharma Co Ltd-Company Statement 18

Sumitomo Dainippon Pharma Co Ltd-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Joint Venture 21

Section 2-Company Analysis 22

Sumitomo Dainippon Pharma Co Ltd-Business Description 22

Sumitomo Dainippon Pharma Co Ltd-Corporate Strategy 23

Sumitomo Dainippon Pharma Co Ltd-SWOT Analysis 24

SWOT Analysis-Overview 24

Sumitomo Dainippon Pharma Co Ltd-Strengths 24

Sumitomo Dainippon Pharma Co Ltd-Weaknesses 25

Sumitomo Dainippon Pharma Co Ltd-Opportunities 26

Sumitomo Dainippon Pharma Co Ltd-Threats 27

Sumitomo Dainippon Pharma Co Ltd-Key Competitors 28

Section 3-Company Financial Ratios 29

Financial Ratios-Capital Market Ratios 29

Financial Ratios-Annual Ratios 30

Performance Chart 33

Financial Performance 33

Financial Ratios-Ratio Charts 34

Section 4-Company's Lifesciences Financial Deals and Alliances 35

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 36

Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary 37

Section 5-Company's Recent Developments 38

Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S. 38

Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change 39

Jun 01, 2017: Sumitomo Dainippon Pharma Contributes funding to the Global Health Innovative Technology Fund (GHIT Fund) for the Second Period 40

May 08, 2017: Sumitomo Dainippon Pharma announces personnel change 41

Apr 10, 2017: Hitachi is selected by Sumitomo Dainippon Pharma for Automated Cell Mass Culture Equipment for Regenerative Medicine using Human iPS Cells 42

Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers 43

Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology 44

Feb 24, 2017: Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers 46

Nov 11, 2016: Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes Related to Officers and Other Key Positions 47

Oct 27, 2016: Sumitomo Dainippon Pharma Announces the Establishment of a Subsidiary for Promotion of Authorized Generics 49

Section 6-Appendix 50

Methodology 50

Ratio Definitions 50

About GlobalData 54

Contact Us 54

Disclaimer 54

List of Figures

Sumitomo Dainippon Pharma Co Ltd, Performance Chart (2013-2017) 33

Sumitomo Dainippon Pharma Co Ltd, Ratio Charts 34

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 36

List of Tables

Sumitomo Dainippon Pharma Co Ltd, Key Facts 6

Sumitomo Dainippon Pharma Co Ltd, Key Employees 7

Sumitomo Dainippon Pharma Co Ltd, Key Employee Biographies 9

Sumitomo Dainippon Pharma Co Ltd, Major Products and Services 10

Sumitomo Dainippon Pharma Co Ltd, History 11

Sumitomo Dainippon Pharma Co Ltd, Other Locations 19

Sumitomo Dainippon Pharma Co Ltd, Subsidiaries 20

Sumitomo Dainippon Pharma Co Ltd, Joint Venture 21

Sumitomo Dainippon Pharma Co Ltd, Key Competitors 28

Sumitomo Dainippon Pharma Co Ltd, Ratios based on current share price 29

Sumitomo Dainippon Pharma Co Ltd, Annual Ratios 30

Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...1) 31

Sumitomo Dainippon Pharma Co Ltd, Annual Ratios (Cont...2) 32

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 35

Sumitomo Dainippon Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 36

Sumitomo Dainippon Pharma Co Ltd, Recent Deals Summary 37

Currency Codes 50

Capital Market Ratios 50

Equity Ratios 51

Profitability Ratios 51

Cost Ratios 52

Liquidity Ratios 52

Leverage Ratios 53

Efficiency Ratios 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sumitomo Dainippon Pharma Co Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8073
Site License
USD 250 INR 16145
Corporate User License
USD 375 INR 24218

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com